Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Body Weight × Sitagliptin Phosphate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 2 Thyroid Nodule 1 Neoplasms, Adipose Tissue 1 Insulin Resistance 1 Diabetes Mellitus, Type 2 1 Breast Neoplasms 1 Body Weight 1

Interventions

Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination 1 Sitagliptin Phosphate 1 Metformin 1 Doxorubicin 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02941445 2016-10-21

Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss

University Medical Centre Ljubljana

Phase 4 Completed

Body Weight, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡